- Home
- GNTY vs CMRX Comparison
GNTY vs CMRX Comparison
Compare GNTY & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTY
- CMRX
- Stock Information
- Founded
- GNTY 1913
- CMRX 2000
- Country
- GNTY United States
- CMRX United States
- Employees
- GNTY N/A
- CMRX N/A
- Industry
- GNTY Major Banks
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- GNTY Finance
- CMRX Health Care
- Exchange
- GNTY Nasdaq
- CMRX Nasdaq
- Market Cap
- GNTY 472.6M
- CMRX 394.1M
- IPO Year
- GNTY 2017
- CMRX 2013
- Fundamental
- Price
- GNTY $40.17
- CMRX $5.15
- Analyst Decision
- GNTY Hold
- CMRX Strong Buy
- Analyst Count
- GNTY 3
- CMRX 2
- Target Price
- GNTY $37.33
- CMRX $8.50
- AVG Volume (30 Days)
- GNTY 37.1K
- CMRX 1.7M
- Earning Date
- GNTY 04-14-2025
- CMRX 03-07-2025
- Dividend Yield
- GNTY 2.40%
- CMRX N/A
- EPS Growth
- GNTY 7.03
- CMRX N/A
- EPS
- GNTY 2.74
- CMRX N/A
- Revenue
- GNTY $120,816,000.00
- CMRX $159,000.00
- Revenue This Year
- GNTY N/A
- CMRX N/A
- Revenue Next Year
- GNTY $4.48
- CMRX $1,690.28
- P/E Ratio
- GNTY $14.61
- CMRX N/A
- Revenue Growth
- GNTY 1.11
- CMRX N/A
- 52 Week Low
- GNTY $27.01
- CMRX $0.75
- 52 Week High
- GNTY $42.95
- CMRX $5.53
- Technical
- Relative Strength Index (RSI)
- GNTY 50.53
- CMRX 76.25
- Support Level
- GNTY $39.90
- CMRX $3.94
- Resistance Level
- GNTY $41.95
- CMRX $5.53
- Average True Range (ATR)
- GNTY 0.96
- CMRX 0.30
- MACD
- GNTY -0.34
- CMRX 0.07
- Stochastic Oscillator
- GNTY 9.98
- CMRX 78.29
About GNTY Guaranty Bancshares Inc.
Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.